Description:[0001] The present invention relates to an asthma exacerbation management system that is capable of detecting coughing of a user to assess asthma symptoms and determines the need for medication to deliver aerosolized treatment, and further monitors air quality to protect the user from harmful pollutants.

BACKGROUND OF THE INVENTION

[0002] Asthma is a chronic respiratory condition characterized by inflammation and narrowing of the airways, leading to symptoms such as wheezing, shortness of breath, chest tightness, and coughing. Among these, persistent or sudden coughing is often an early indicator of an impending asthma exacerbation. In many cases, individuals may not recognize the severity or the underlying cause of their coughing, especially during the early stages of an asthma attack. Timely assistance in identifying and responding to such coughing episodes is crucial to prevent the condition from worsening. Traditional asthma management relies heavily on self-awareness and manual administration of medication, which may not always be timely or accurate, particularly in children, the elderly, or individuals with limited mobility or awareness. Therefore, there is a growing need for automated systems that can monitor cough characteristics—such as frequency, duration, and intensity—to detect early signs of asthma exacerbations. These systems can assist users by alerting them to their condition and administering the appropriate medication, such as aerosolized bronchodilators, to relieve airway constriction. Furthermore, integrating real-time air quality monitoring can help prevent further irritation by shielding users from asthma-triggering pollutants. Thus, smart assistance for cough-related symptoms plays a vital role in the proactive and personalized management of asthma.

[0003] In cases of asthma exacerbation, individuals may struggle with effective coughing due to airway obstruction, mucus buildup, or respiratory muscle fatigue. To assist with coughing, various equipment is used, including manual chest physiotherapy tools, mechanical insufflation-exsufflation devices (commonly known as cough assist machines), and positive expiratory pressure (PEP) devices. Cough assist machines work by delivering a gentle positive pressure breath followed by a rapid shift to negative pressure, simulating a natural cough to help expel mucus from the lungs. PEP devices create resistance during exhalation, keeping the airways open and promoting mucus clearance. While these devices can be highly effective in supporting airway clearance, they come with certain drawbacks. Cough assist machines can be expensive, bulky, and require proper training for safe and effective use, making them less accessible for home use. They may also be uncomfortable or poorly tolerated by some users, especially children or those with anxiety. PEP devices, though more portable, rely heavily on user cooperation and consistent technique, which can be difficult during severe asthma attacks. Manual chest physiotherapy requires caregiver support and can be physically taxing. Overall, while these tools offer valuable support, their limitations highlight the need for individualized treatment plans and proper medical supervision.

[0004] JP2006181340A discloses an asthma diagnosis device includes: a reference laughing voice storage part storing the laughing voice of a slight asthmatic as reference data; an input part inputting the laughing voice of the diagnosis subject; a similarity determination part for determining the similarity of the laughing voice as the reference data to the input laughing data; and an output part for outputting the determination result of the similarity.

[0005] WO0136032A1 discloses a device for use in administrating an asthma drug into a patient is provided with a cap having a drug introduction hole through which the asthma drug is introduced into the device and an inhalation tube through which the patient inhales the asthma drug within the patient, and a peripheral protrusion formed around a skirt of the cap. A transparent bellows is contractible and expandable and fixed with the cap at its upper end. An insertion plate is fixed with a lower end of the transparent bellows. The insertion plate has a groove with which the peripheral protrusion is engaged.

[0006] Conventionally, many devices have been developed to manage administration of asthma medicine, however these existing devices mentioned in the prior arts have limitations pertaining to shielding user from poor air quality to prevent further exacerbations via an equipped shielding configurational support.

[0007] In order to overcome the aforementioned drawbacks, there exists a need in the art to develop a system that requires to be capable of analyzing coughing condition of user for detection of asthma exacerbations, and accordingly the system needs to deliver aerosolized medicine and further monitors surrounding air to protect the user from asthma-triggering pollutants via an equipped shielding configurational support.

OBJECTS OF THE INVENTION

[0008] The principal object of the present invention is to overcome the disadvantages of the prior art.

[0009] An object of the present invention is to develop a system that is capable of assessing medical condition of a user related to coughing of the user to detect potential asthma exacerbations to evaluate requirement of medicine administration.

[0010] Another object of the present invention is to develop a system that is capable of facilitating delivery of aerosolized medicine to the user for relief from the asthma exacerbations.

[0011] Yet another object of the present invention is to develop a system that is capable of assessing air quality to the surroundings of the user and accordingly shields the user from inhalation of airborne pollutants for preventing further asthma exacerbations.

[0012] The foregoing and other objects, features, and advantages of the present invention will become readily apparent upon further review of the following detailed description of the preferred embodiment as illustrated in the accompanying drawings.

SUMMARY OF THE INVENTION

[0013] The present invention relates to an asthma exacerbation management system that is capable of assessing cough-related health conditions to identify asthma exacerbations, accordingly administers aerosol medicine to the user as needed, and shields the user from poor air quality to prevent further exacerbations.

[0014] According to an embodiment of the present invention, an asthma exacerbation management system, comprises of a spraying unit configured with a microphone for capturing voice signals from surroundings, a microcontroller is operatively coupled to the microphone for processing the signals to detect and analyze cough parameters such as frequency, pitch and duration in a user accessing the spraying unit, to identify asthma symptoms in the user, ensuring precise detection of potential asthma exacerbations, a multi-sectioned container incorporated within the spraying unit and is storing a liquid medicinal solution and an aerosolized medicine, the microcontroller evaluates an appropriate amount and type of medication to be administered to the user, ensuring a personalized response to the user’s condition, a speaker installed on the spraying unit designed to emit auditory signals that notifies the user regarding appropriate medication dosage, a holographic projection unit mounted on the spraying unit to project three-dimensional cues for providing real-time guidance to the user on optimal positioning of an opening of the spraying unit and follow proper inhalation techniques, and an artificial intelligence-based imaging unit mounted on the spraying unit to detect placement of the opening with the mouth portion.

[0015] According to another embodiment of the present invention, the system further comprises of an ECV (Electronically Controlled Valve) installed in one section of the container, to dispense the evaluated amount of the medicinal liquid from the container, that is to be inhaled by the user facilitating delivery of the medication directly into the user’s respiratory system to mitigate asthma attack symptoms, a hemispherical shaped wearable body having a flap, integrated with an inbuilt processing unit linked with the microcontroller, having a sensing unit including but not limited to an air quality sensor and a dust sensor for continuous monitoring of air quality within the user’s immediate surroundings, and upon detecting presence of adverse environmental data from a pre-fed data stored in a database, to assess potential risk of asthma exacerbation, thus enabling proactive intervention, a primary and secondary set of extendable rods, attached on a lower side of the flap, a motorized roller coiled with a breathable fabric, are assembled between each of the primary and secondary set of rods for extending to positon the fabric to securely cover the user’s mouth and nose, thus forming a protective barrier which shields the user from inhalation of airborne pollutants, allergens and other potential asthma-inducing agents, thereby reducing likelihood of the asthma exacerbations.

[0016] While the invention has been described and shown with particular reference to the preferred embodiment, it will be apparent that variations might be possible that would fall within the scope of the present invention.

BRIEF DESCRIPTION OF THE DRAWINGS

[0017] These and other features, aspects, and advantages of the present invention will become better understood with regard to the following description, appended claims, and accompanying drawings where:
Figure 1 illustrates an isometric view of an asthma exacerbation management system.

DETAILED DESCRIPTION OF THE INVENTION

[0018] The following description includes the preferred best mode of one embodiment of the present invention. It will be clear from this description of the invention that the invention is not limited to these illustrated embodiments but that the invention also includes a variety of modifications and embodiments thereto. Therefore, the present description should be seen as illustrative and not limiting. While the invention is susceptible to various modifications and alternative constructions, it should be understood, that there is no intention to limit the invention to the specific form disclosed, but, on the contrary, the invention is to cover all modifications, alternative constructions, and equivalents falling within the spirit and scope of the invention as defined in the claims.

[0019] In any embodiment described herein, the open-ended terms "comprising," "comprises,” and the like (which are synonymous with "including," "having” and "characterized by") may be replaced by the respective partially closed phrases "consisting essentially of," consists essentially of," and the like or the respective closed phrases "consisting of," "consists of, the like.

[0020] As used herein, the singular forms “a,” “an,” and “the” designate both the singular and the plural, unless expressly stated to designate the singular only.

[0021] The present invention relates to an asthma exacerbation management system that is capable of monitoring coughing to evaluate asthma risk, provides aerosol medication to the user for relief, and ensures user protection by detecting and responding to air quality threats by providing a shield to the user’s mouth portion.

[0022] Referring to Figure 1, an isometric view of an asthma exacerbation management system is illustrated, comprises of a spraying unit 101 associated with a system 102 configured with a microphone 103, a multi-sectioned container 104 incorporated within the spraying unit 101 in an opening 105 of the spraying unit 101, a speaker 106 installed on the spraying unit 101, a holographic projection unit 107 mounted on the spraying unit 101, an artificial intelligence-based imaging unit 108 mounted on the spraying unit 101, a breath sensor 109 mounted on the opening 105 of the spraying unit 101.

[0023] Figure 1 further illustrates an ECV (Electronically Controlled Valve) 110 installed in one section of the container 104, a health monitoring module 111 integrated in the spraying unit 101, a hemispherical shaped wearable body 112 associated with the system 102, a flap 113 attached with the body 112, a sensing unit 114 embedded in the body 112, a primary and secondary set of extendable rods 115, attached on a lower side of the flap 113, a motorized roller 116 coiled with a breathable fabric 117 are assembled between each of the primary and secondary set of rods 115.

[0024] The present invention includes a spraying unit 101 associated with a system 102 incorporating various components associated with the system, developed to analyze coughing voice of a user for detection of potential asthma exacerbations. An inbuilt microcontroller of the spraying unit 101 is responsible for operating of all the linked components for performing their respective functions upon actuation. The microcontroller, mentioned herein, is preferably an Arduino microcontroller. The Arduino microcontroller used herein controls the overall functionality of the linked components.

[0025] The spraying unit 101 is integrated with a microphone 103 for capturing voice signals from surroundings. The microphone 103 turns the sound energy emitted by the user into electrical energy. The sound waves created by the user carry energy towards the microphone 103. Inside the microphone 103, a diaphragm, made of plastic, is present and moves back and forth when the sound wave hits the diaphragm. The coil attached to the diaphragm also moves in same way. The magnetic field produced by the permanent magnet cuts through the coil. As the coil moves, the electric current flows. The electric current from coil flows to an amplifier which convert the sound into electrical signal. The microcontroller linked to the microphone 103 recognize the voice to detect and analyze cough parameters such as frequency, pitch and duration in a user accessing the spraying unit 101.

[0026] The microcontroller via the microphone 103 identifies asthma symptoms in the user, ensuring precise detection of potential asthma exacerbations. The microcontroller processes the identified symptoms of the soughing of the user and compares with a pre-stored data from a linked database. Based upon the comparison, the microcontroller evaluates an appropriate amount and type of medication to be administered to the user, ensuring a personalized response to the user’s condition.

[0027] The spraying unit 101 incorporates a multi-sectioned container 104 to store a liquid medicinal solution and an aerosolized medicine. The microcontroller activates a speaker 106 installed on the spraying unit 101 designed to emit auditory signals that notifies the user regarding appropriate medication dosage.

[0028] The speaker 106 works by taking the input signal from the microcontroller, it then processes and amplifies the received signal through a series of equipment in a specific order within the speaker 106, and then sends the output signal in form of audio notification through the speaker 106 for alerting the user to grip the spraying unit 101 for requirement of intake of appropriate medication dosage for curing the detected asthma exacerbations.

[0029] While the user accesses and hold the spraying unit 101 for intake of medication, a health monitoring module 111 is integrated in the spraying unit 101 to analyze vital health parameters of the user including but not limited to heart rate, blood pressure and body 112 temperature.

[0030] The health monitoring module 111 include a PPG (photo-plethysmography) sensor, a blood pressure sensor and a temperature sensor. The health monitoring module 111 integrated into the system 102 is designed to continuously track the user's vital health parameters, ensuring timely detection of any physiological changes that signal an impending asthma attack or related health issues. The PPG (photo-plethysmography) sensor, uses light-based application to measure the user’s heart rate by detecting blood volume changes in the microvascular bed of tissue, typically through the skin. Alongside this, the blood pressure sensor monitors both systolic and diastolic pressure levels, providing critical information about the user’s cardiovascular status, which is essential in evaluating stress or exertion levels that exacerbate asthma symptoms.

[0031] Additionally, the temperature sensor is included to measure the user’s body 112 temperature, helping identify fever or infections that could influence respiratory conditions. All the collected data of the health monitoring module 111 is transmitted to the microcontroller, which analyzes these health metrics in real-time. By cross-referencing this information with pre-set thresholds from the linked database, the microcontroller accordingly verifies the symptoms of the user with the vital health parameters, thus ensuring negligible errors in detection of asthma attacks.

[0032] The spraying unit 101 is configured with a holographic projection unit 107 for guiding user to access the spraying unit 101 for medical dosage administration. In case the appropriate medication corresponds to inhaling medicinal liquid, the microcontroller activates the holographic projection unit 107 to project three-dimensional cues for providing real-time guidance to the user on optimal positioning of an opening 105 of the spraying unit 101 to the mouth of the user.

[0033] The holographic projection unit 107 uses interference patterns of light to create realistic three-dimensional images in mid-air. The projection unit 107 typically consists of a laser source, beam splitters, mirrors, and a holographic screen or projection surface. The projection unit 107 projects light onto a surface from multiple angles, using the interference of light waves to produce 3D images visible from different perspectives. The projected visuals guide the user in positioning of an opening 105 of the spraying unit 101 to the mouth of the user.

[0034] The user is required to perform the guided actions for accessing and opening 105 the spraying unit 101 and engage the spraying unit 101 with the mouth portion for following proper inhalation techniques to get comforted from the sudden coughing related to asthma disease.

[0035] Synchronously, the microcontroller generates a command to activate an artificial intelligence-based imaging unit 108 integrated on the spraying unit 101 for capturing multiple images in a vicinity of the spraying unit 101, respectively to detect placement of the opening 105 with the mouth portion. The imaging unit 108 incorporates a processor that is encrypted with an artificial intelligence protocol. The artificial intelligence protocol operates by following a set of predefined instructions to process data and perform tasks autonomously. Initially, data is collected and input into a database, which then employs protocol to analyze and interpret the captured images. The processor of the imaging unit 108 via the artificial intelligence protocol processes the captured images and sent the signal to the microcontroller to detect placement of the opening 105 with the mouth portion.

[0036] In response to administration of medical dosage, the microcontroller activates an ECV 110 (Electronically Controlled Valve) installed in one section of the container 104, to dispense the evaluated amount of the medicinal liquid from the container 104.

[0037] The ECV 110, used herein, is a short tube with a taper integrated with fine-tuned valve or orifice that is electronically regulated to speed up or regulate the flow of the medicinal liquid. The ECV 110 controls flow of medicinal liquid by varying the size of the flow passage as directed by a signal from the microcontroller. This enables the direct control of flow rate and the consequential control of process quantities such as pressure, and medicinal liquid level in view of dispensing the medicinal liquid as per the determined requirement.

[0038] During the positioning of mouth portion, the microcontroller that is to be inhaled by the user facilitating delivery of the medication directly into the user’s respiratory system 102 to mitigate asthma attack symptoms. The opening 105 of the spraying unit 101 is mounted with a breath sensor 109 for detecting breathing pattern of the user along with inhalation pressure of the user. The breath sensor 109 functions by continuously monitoring the user’s breathing pattern and inhalation pressure. The breath sensor 109 detects the airflow variations as the user inhales and exhales, using sensitive pressure and flow sensors to measure the depth, rhythm, and strength of each breath. When the user begins to inhale, the sensor captures the initial drop in pressure, signalling the microcontroller to prepare the medication for delivery.

[0039] The breath sensor 109 then analyses the inhalation flow rate and pressure to determine whether the user is inhaling with sufficient force and consistency for effective medication delivery. Based upon the detected breathing pattern of the user, the microcontroller regulates operation of the nozzle for ensuring optical dosage is delivered to the user for mitigating the symptoms of the asthma attack.

[0040] The system 102 incorporates a hemispherical shaped wearable body 112 having a flap 113. The body 112 having an inbuilt processing unit and linked with the microcontroller for controlling operations of the connected components via a communication module.

[0041] The communication module includes, but not limited to Wi-Fi (Wireless Fidelity) module, Bluetooth module, GSM (Global System 102 for Mobile Communication) module. The Wi-Fi module contains transmitters and receivers that use radio frequency signals to transmit data wirelessly to the microcontroller. The wireless module typically includes components such as antennas, amplifiers, and processors to facilitate communication and further connected to networks such as Wi-Fi, Bluetooth, or cellular networks, allowing devices to exchange information over short or long distances for communication of wireless commands to facilitate operations of the system.

[0042] Post successful administering of the medication to the user, the microcontroller directs the speaker 106 to guide the user to wear the body 112 on the user’s head in order to prevent further potential risk of asthma exacerbation.

[0043] The body 112 is developed to be worn by the user on the user’s head. A sensing unit 114 is embedded in the body 112 operable via the processing unit for continuous monitoring of air quality within the user’s immediate surroundings. The sensing unit 114 multiple sensors include but not limited to an air quality sensor and a dust sensor. The Air quality sensor operate by detecting and measuring various pollutants and particulate matter in the air. The air quality works upon sensors including optical, electrochemical, or semiconductor-based sensors. The air quality sensor analyzes air samples for pollutants such as carbon dioxide, particulate matter, volatile organic compounds (VOCs), and other contaminants. The concentration of these elements is then converted into electrical signals and processed by the microcontroller via the processing unit.

[0044] The dust sensor detects the presence of dust by monitoring the particles. The dust sensor uses an optical sensing method to detect dust. A photo sensor and an infrared light-emitting diode are optically arranged in the dust sensor. The photo-sensor detects the reflected rays which are bounced off the pollutants of the air. The bounced back rays are processed by the microcontroller via the processing unit.

[0045] The microcontroller via the processing unit analyses the collected data of the sensing unit 114 and compares with a pre-fed data stored in the database. The microcontroller via the processing unit accordingly evaluates presence of adverse environmental to assess potential risk of asthma exacerbation, thus enabling proactive intervention.

[0046] The lower side of the flap 113 are equipped with a primary and secondary set of extendable rods 115. Each of the primary and secondary set of rods 115 are arranged with a motorized roller 116 coiled with a breathable fabric 117. The extension and retraction of the rods 115 is powered by achieved through a telescoping arrangement consisting of multiple nested segments that slide in and out of each other.

[0047] In case the microcontroller via the processing unit evaluates adverse air quality of the immediate surroundings, the microcontroller via the processing unit synchronously actuates the telescoping arrangement of the rods 115 for extension/retraction of the rods 115. These segments are designed to smoothly extend or retract along a central axis. The microcontroller via the processing unit controls the movement by activating a motorized actuator connected to the rods 115.

[0048] The actuator of the telescopic arrangement is typically a linear motor that applies force to the innermost segment, pushing it outward for extension or pulling it back inward for retraction. This motion is precise, allowing the rods 115 to extend and retract smoothly without jamming. The telescopic arrangement provided support to the flap 113, in view of ensuring proper deployment of the breathable fabric 117 in front of the mouth and nose portion of the user. The deployment of the fabric 117, forms a protective barrier which shields the user from inhalation of airborne pollutants, allergens and other potential asthma-inducing agents, thereby reducing likelihood of the asthma exacerbations.

[0049] In an embodiment of the present invention, the body 112 is configured with a camera which works in sync with an ultrasonic sensor to determine the face dimensions of the user. The microcontroller via the processing unit actuates the roller 116 for loosening/tightening of the breathable fabric 117 over the mouth and nose portion of the user such that provides a comfortable snug fit over the user’s face.

[0050] The spraying unit 101 incorporates a GPS (Global Positioning System) module for tracking real-time location of the body 112. The GPS (Global Positioning System) module working in sync with a magnetometer provides enhanced positioning and orientation information of the body 112. The GPS module receives signals from multiple satellites in orbit around the Earth. These satellites transmit precise timing and position information of the body 112. The GPS module receives these signals and uses the time delay between transmission and reception to calculate the distance between the GPS module and each satellite. By triangulating the distances from multiple satellites, the GPS module determines its own position on the Earth's surface. This position is typically given in latitude and longitude coordinates.

[0051] The magnetometer of the GPS module measures the strength and direction of the magnetic field in its vicinity. The magnetometer detects the Earth's magnetic field, which is approximately aligned with the Earth's geographic north-south axis. By utilizing the magnetometer's measurements, the GPS module determine the band heading or orientation relative to magnetic north. The magnetometer provides information about the direction of the Earth's magnetic field, which is compared with the band position information obtained from the GPS module. The outputs of the GPS module and the magnetometer are combined and processed by the microcontroller via the processing unit in order to determine the location of the body 112.

[0052] Based on the detected location of the body 112, the microcontroller via the processing unit assesses the air quality of the surroundings via the sensing unit 114. The microcontroller via the processing unit accordingly updates the air quality, allergens and pollution levels into the database, in view of regulating health management. The user is kept informed regarding the levels of air quality of the area over connected computing unit of the user via the communication module.

[0053] A battery (not shown in figure) is associated with the system to supply power to electrically powered components which are employed herein. The battery is comprised of a pair of electrodes named as a cathode and an anode. The battery uses a chemical reaction of oxidation/reduction to do work on charge and produce a voltage between their anode and cathode and thus produces electrical energy that is used to do work in the system.

[0054] The present invention works best in the following manner, where the present invention includes involves the spraying unit 101 equipped with the microphone 103 that captures voice signals, particularly cough sounds, which are processed by the microcontroller to analyze parameters such as frequency, pitch, and duration for detecting asthma symptoms. Upon detection, the microcontroller references the linked database to determine the suitable medication from the multi-sectioned container 104 housing both the liquid medicinal solution and the aerosolized medicine. The speaker 106 on the spraying unit 101 alerts the user about dosage, and if liquid inhalation is required, the holographic projection unit 107 provides real-time 3D cues for positioning the unit and guiding inhalation. The breath sensor 109 on the opening 105 detects inhalation pressure and breathing pattern, helping the microcontroller regulate the nozzle for accurate dosing. The imaging unit 108 and processor identify the alignment of the user's mouth with the opening 105, triggering the Electronically Controlled Valve (ECV 110) to dispense the correct dosage. After medication, the speaker 106 instructs the user to wear the hemispherical shaped wearable body 112 with the flap 113, where the air quality sensor and dust sensor monitor the environment. If poor air quality is detected, the microcontroller via the processing unit actuates extendable rods 115 and the motorized roller 116 with breathable fabric 117 to shield the user’s mouth and nose. Additionally, the health monitoring module 111 with PPG, blood pressure, and temperature sensors tracks vital signs, while the GPS module retrieves location-based air quality and pollution data, ensuring timely and precise asthma management.

[0055] Although the field of the invention has been described herein with limited reference to specific embodiments, this description is not meant to be construed in a limiting sense. Various modifications of the disclosed embodiments, as well as alternate embodiments of the invention, will become apparent to persons skilled in the art upon reference to the description of the invention. , Claims:1) An asthma exacerbation management system, comprising:

i) a spraying unit 101 configured with a microphone 103 for capturing voice signals from surroundings, wherein a microcontroller is operatively coupled to said microphone 103 for processing said signals to detect and analyze cough parameters such as frequency, pitch and duration in a user accessing said spraying unit 101, which are subsequently analyzed by said microcontroller to identify asthma symptoms in said user, ensuring precise detection of potential asthma exacerbations;
ii) a multi-sectioned container 104 incorporated within said spraying unit 101 and is storing a liquid medicinal solution and an aerosolized medicine, wherein said microcontroller processes said identified symptoms to compare with a pre-stored data from a linked database, based on which said microcontroller evaluates an appropriate amount and type of medication to be administered to said user, ensuring a personalized response to said user’s condition;
iii) a speaker 106 installed on said spraying unit 101 designed to emit auditory signals that notifies said user regarding appropriate medication dosage, wherein in instances where said appropriate medication corresponds to inhaling medicinal liquid, said microcontroller activates a holographic projection unit 107 mounted on said spraying unit 101 to project three-dimensional cues for providing real-time guidance to said user on optimal positioning of an opening 105 of said spraying unit 101 and follow proper inhalation techniques;
iv) an artificial intelligence-based imaging unit 108 paired with a processor, mounted on said spraying unit 101 for capturing and processing multiple images in vicinity of said spraying unit 101, respectively to detect placement of said opening 105 with said mouth portion, said microcontroller activates an ECV 110 (Electronically Controlled Valve) installed in one section of said container 104, to dispense said evaluated amount of said medicinal liquid from said container 104, that is to be inhaled by said user facilitating delivery of said medication directly into said user’s respiratory system 102 to mitigate asthma attack symptoms;
v) a hemispherical shaped wearable body 112 having a flap 113, integrated with an inbuilt processing unit linked with said microcontroller, wherein upon successful administering of said medication, said microcontroller directs said speaker to guide said user to wear said body on said user’s head, to allow a sensing unit 114 including but not limited to an air quality sensor and a dust sensor, installed in said body 112 for continuous monitoring of air quality within said user’s immediate surroundings, and upon detecting presence of adverse environmental data from a pre-fed data stored in a database, to assess potential risk of asthma exacerbation, thus enabling proactive intervention; and
vi) a primary and secondary set of extendable rods 115, attached on a lower side of said flap 113, wherein a motorized roller 116 coiled with a breathable fabric 117, are assembled between each of said primary and secondary set, and in case said adverse air quality is detected, said microcontroller via said processing unit synchronously actuates said rods 115 for extending to positon said fabric 117 to securely cover said user’s mouth and nose, thus forming a protective barrier which shields said user from inhalation of airborne pollutants, allergens and other potential asthma-inducing agents, thereby reducing likelihood of said asthma exacerbations.

2) The system 102 as claimed in claim 1, wherein a breath sensor 109 is mounted on said opening 105 for detecting breathing pattern, along with inhalation pressure of said user, based on which said microcontroller regulates operation of said nozzle for ensuring optical dosage is delivered.

3) The system 102 as claimed in claim 1, wherein a health monitoring module 111 having a PPG (photo-plethysmography) sensor, a blood pressure sensor and a temperature sensor for measuring vital health parameters of said user including but not limited to heart rate, blood pressure and body 112 temperature, based on which said microcontroller identifies symptoms, thus ensuring negligible errors in detection of asthma attacks.

4) The system 102 as claimed in claim 1, wherein a GPS (Global Positioning System) module installed on said spraying unit 101 for tracking real-time location of said spraying unit 101, based on which said microcontroller fetches air quality, allergens and pollution levels from said database, in view of regulating health management.

5) The system 102 as claimed in claim 1, wherein a battery is associated with said system 102 for powering up electrical and electronically operated components associated with said system 102.